Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reduced dose capecitabine deemed effective treatment in metastatic breast cancer
January 12th, 2006
Reduced dose capecitabine was deemed an effective treatment in patients with metastatic breast cancer. According to a study from England, "Fifty-seven patients with metastatic breast cancer have been treated with reduced dose capecitabine 1 g/m2 twice daily for 14 days repeated every 3 weeks after failure of a number of chemotherapy regimens or hormonal treatment. The overall objective response rate was 28% with 2% complete response rate and 26% partial response." "Twenty nine percent objective response rate was achieved in 17 patients pretreated with anthracyclines and taxanes. The median duration of response and survival were 8.5 and 9...
Source: Women's Health Weekly (2006-01-12)
|
